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Background: Metastasis is the cause of most cancer 
related morbidity. A naturally occurring cysteine pro-
tease inhibitor, cystatin C, has been reported to inhibit 
tumor cell metastasis for several different cancer types, 
however, the mechanism is still unknown. Our study 
focused on determining which region of cystatin C is 
responsible for anti-metastatic action by characterizing 
specific constructs of cystatin C in melanoma cells.  In 
one construct, the N-terminal peptide amino acids 1-
10, required for cysteine protease inhibition, were de-
leted. In the second construct the conserved motif 
QLVA was altered to GGGG. Methods and Results: 
Net proliferation, migration and invasion of the cys-
tatin C constructs were assessed. The modified Boyden 
chamber revealed 75% reduced invasion of N-
truncated clones compared to control B16F10, similar 
to cystatin C overexpression. A scratch migration as-
say also showed a three-fold reduction in migration 
rate. The QLVA sequence was found to be required for 
inhibition of B16F10 invasion and migration. Net cell 
proliferation remained constant between clones. Con-
clusions: Overexpression of cystatin C with or without 
cysteine protease inhibitor activity inhibits the migra-
tion and invasion, but not proliferation, of B16F10 
melanoma cells. The conserved cystatin sequence, 
QLVA, is required for cystatin actions on B16 mela-
noma cells.  
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Introduction 
 
Metastatic melanoma is an aggressive disease that is 
characterized by rapid systemic dissemination. The 
main cause of death in melanoma patients is wide-
spread metastases. If caught early and treated before 
melanoma is able to metastasize the 5-year survival 
rate is greater than 95%, however, patients with metas-
tatic melanoma have a 5-year survival of less than 10% 
(Tas 2012). Progression of melanoma involves a criti-
cal change from low metastatic, radial phase growth to 
higher metastatic, vertical phase growth. This is the 
basis for the prognostic value of the Breslow index for 
melanoma. As melanoma progresses, the cells invade 
through the basement membrane into the dermis and 
eventually into the peripheral lymphatic vessels and 
vasculature. A chief feature of invasive melanoma 
cells is the increased production of extracellular prote-
ases for extracellular matrix (ECM) degradation. Sev-
eral families of proteolytic enzymes are involved in 
tumor cell ECM degradation including MMPs, cathep-
sins, and plasminogen activator types in particular 
(Mason & Joyce 2011, 2012, Tan et al. 2013). In addi-
tion to their role in ECM degradation, the cathepsins 
also have roles in tumor cell proliferation and angio-
genesis (Gocheva et al. 2006). Since several cathepsins 
are upregulated in most malignant tumor types, their 
inhibition may be of therapeutic benefit to control cer-
tain cancer metastases. 
 Cystatin C, a widely expressed cysteine prote-
ase inhibitor of about 14kD, has been shown to be a 
“metastasis suppressor” when overexpressed in cancer 
cells or in mice (Cox et al. 1999, Kopitz et al. 2005, 
Wegiel et al. 2009). Overexpression of cystatin C in 
murine melanoma cells results in decreased cell migra-
tion and metastasis (Ervin & Cox 2005). While the 
decreased metastasis upon cystatin C overexpression 
could be related to the decreased melanoma cell migra-
tion/invasion, it is more likely due to the increased 
apoptosis observed in melanoma metastases. This is 
because the growth of metastases at secondary sites is 
believed to be the metastasis rate limiting step 
(Chambers et al. 2001). The mechanisms for these ef-
fects are not well understood. 
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 Considering that 1) overexpression of cystatin 
C results in decreased melanoma migration and metas-
tasis; 2) exact sequences for cathepsin B inhibition by 
cystatin C have been evaluated; and 3) complete inhi-
bition of all cysteine proteases would probably not in-
hibit melanoma migration and metastasis to cystatin 
overexpression levels observed, we explored the possi-
bility of cystatin C inhibiting metastasis and migration 
through a different functional pathway, besides acting 
as a cysteine protease inhibitor. Since the cystatin se-
quence QVVAG is evolutionarily conserved in all cys-
tatins and plays a minor role in cysteine protease inhi-
bition, we compared this region to an N-terminal 10 
amino acid cystatin deletion which is deficient for cys-
teine protease binding and inhibition (Abrahamson et 
al. 1991, Jerala et al. 1990). We analyzed expression 
of loss of function mutation of QLVA in murine cys-
tatin C and, in a second mutation, the first 10 amino 
acid deletion of cystatin on migration, invasion, prolif-
eration and cellular morphology in B16F10 (high me-
tastatic) melanoma cells. 
 
Materials and Methods 
 
Cell line and Growth  
B16F10 melanoma cells were obtained from ATCC.  
Cells were grown in RPMI1640 medium (Cambrex) 
containing 10% fetal bovine serum (FBS) (Atlanta 
Biologicals) and 1% stock antibiotic solution (100 IU/
ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml am-
photericin) (Sigma Chemical). 
 
Cystatin C overexpression clone 
Total RNA was isolated from B16F10 melanoma cells 
to be used for the production of murine cystatin C 
cDNA expression. Reverse transcription of the RNA 
was performed with MMTV reverse transcriptase and 
a 3’ cystatin C primer. PCR amplification with Taq 
polymerase of the reverse transcriptase reaction was 
with 5’ and 3’ cystatin C primers. The PCR product 
was gel purified and ligated into an EcoRV-cut 
pcDNA3 plasmid for expression. Commercial se-
quence analysis showed a murine cystatin C sequence 
identical to that reported in the literature (Huh et al. 
1995). The purified cystatin-pcDNA3 plasmid DNA 
was transfected into B16F10 melanoma cells with li-
pofectamine according to the manufacturer’s instruc-
tions. Isolated clones were selected with cloning rings, 
following transfected cell colony growth in 1mg/ml 
G418. Cystatin overexpression clones were selected by 
western blot analysis after a 48-hour growth in serum 
free media. Samples were run on 12% SDS-PAGE gels 
and electro-blotted to PVDF membranes. Anti-cystatin 
C goat polyclonal antibody (Pierce) was used at 
1:1000 dilution. Secondary antibody, rabbit anti-goat 
IR Dye,800 CW (Li-COR) was used at 1:10,000 and 
detection was performed by the Odyssey infrared 
imager (Li-COR).    
 
Cystatin C Variant Clones 
The clones used in this study consisted of a vector con-
trol (PD-1), a cystatin C overexpressing clone (CC12), 
two N-terminal 10 amino acid deleted cystatin C 
clones  (1-1, 1-7) and two QLAV to GGGG (position 
55-58) clones (4-3, 4-6). Double-stranded, sequence-
verified genomic blocks of each cystatin variant clone 
were ordered (gBlocks® Integrated DNA Technolo-
gies). The ExpressoTM CMV Cloning and Expression 
System from Lucigen® was used for rapid cloning of 
the cystatin construct clones into the pME-HA plas-
mid. A C-terminal human influenza hemagglutinin tag 
(HA) was used for detection of expression of the cys-
tatin construct clones by B16F10 melanoma cells via 
western blotting. Each cystatin C variant clone was 
transfected into B16F10 cells with Lipofectamine 
(Invitrogen) according to the manufacturor’s instruc-
tions. Lipofectamine solution was removed and com-
plete growth media was added to the cells for over-
night incubation. The cells were then trypsinized and 
seeded on 60mm dishes containing 1 mg/ml Geneticin 
(Sigma) for 10-14 days. Geneticin resistant colonies 
were isolated with glass cloning rings and 3-5 minute 
trypsinization with 50 µl trypsin solution, before mov-
ing cell colonies to 24-well plates containing 1 ml 
growth medium in each well. 
 
Verification of Cystatin C Variant Clones 
Western blots were perfomed to identify expression of 
cystatin C variant clones based on the intensity of the 
HA tag band. All clones were grown to near conflu-
ence in 24 well plates in complete RPMI medium and 
then switched to serum free RPMI for 3 days. Media 
(25μl) from each clone was then boiled for 5 minutes 
followed by centrifugation at 5,000 rpm. Samples were 
then ran on 12% SDS PAGE gels and electro-blotted 
to PVDF membranes for antibody detection. Rabbit 
anti-HA (Upstate Biotechnology) was used at 1:1000 
dilution. Secondary antibody, goat anti-rabbit IR 
Dye,800CW (Li-COR) was used at 1:10,000 and de-
tection was by Odyssey infrared imager (Li-COR). 
 
MTT Assay 
For each clone, 5x103 cells in 100 μl of RPMI com-
plete medium were plated per 96 well for a total of 3 
wells per clone. The experiment consisted of wells 
seeded with cells for 0, 24, 48 and 72 hour time points. 
At each time point, media was taken off and replaced 
with 10% MTT stock solution (5mg/ml) with 90% 
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complete RPMI media, followed by incubation at 5% 
CO2 and 37⁰ C for 4 hours. After incubation, the solu-
tion was taken off the cells and 100 µl of isopropanol 
was added. The plate was then placed on a plate rocker 
at 30x speed for 15 minutes, foil covered. Absorption 
readings were measured, immediately after rocking, at 
570 nm. Net proliferation was graphed from the rela-
tive absorption change divided by the absorption at 
time zero for each clone and variant clone. Each assay 
was performed in triplicate, and data is presented as 
mean ± standard error. 
 
Wound Closure Migration Assay (Scratch Assay) 
A reference line was drawn on the bottom of a 24-well 
plate through each well with a fine point permanent 
marker before plating cells. Cells at a density of 4x105 
cells per 2 ml were first plated in a 24-well plate for 12 
hours in serum-containing medium and then an addi-
tional 12 hours with serum-free medium. Cells were 
then scratched in a straight line, perpendicular to the 
reference line, with a 200 μl yellow pipette tip in three 
places in order to create cell-free stripes (scratches).  
Media from each well was replaced after all three 
scratches were made. Digital images were taken imme-
diately after performing the scratches and after 24 
hours using an Olympus inverted microscope (4x ob-
jective). Digital images of cells on the glass coverslips 
were captured with a Motic TM digital camera and Mo-
tic images plus ML application software (version 2.0). 
When using the 4x objective, the field-of-view was 
1875 µm x 1500 µm at the detection surface of the 
camera. Cell migration was measured by change in 
scratch-wound closure by the following formula:  
((Time zero area - Time 24hr area)/ (2*307))/24). 
 
Modified Boyden Chamber 
Invasion was assessed with a modified Boyden cham-
ber (Neuro Probe Inc., Pleasanton, CA) and 8 μm pore 
size polyvinylpyrrolidone (PVP)-free polycarbonate 
filters (Neuro Probe Inc., Pleasanton, CA). The filters 
were coated by pipetting 50 µl Matrigel solution (BD 
MatrigelTM) evenly on top. The lower compartment of 
the chamber was filled with complete media plus 
chemoattractant, 25ng bFGF. The upper and lower 
compartments were separated by a Matrigel-coated 
filter. Melanoma cells (70-90% confluent) were har-
vested in 0.25% tryspin-EDTA solution (3 minutes), 
collected by centrifugation, resuspended in complete 
media and placed in the upper compartment (3x104 
cells/100 µl per well). The invasion assay was per-
formed in triplicate for each clone. After 24 hours of 
incubation at 37ºC, cells on filters were fixed in metha-
nol for 10 minutes, permeabilized for 2 minutes with 
0.1% Triton in PBS, and stained with 2% crystal violet 
for 15 minutes. Cells on the top portion of the mem-
brane were carefully removed with a cotton tip swab 
before mounting on a glass slide with 70% glycerol 
solution. Invading cells were counted using micros-
copy and entire filter was analyzed for invading cells. 
To verify accurate counting the Image J cell counter 
plugin (NIH) was also used. Microscopy was per-




Aspect ratio (elongation), feret diameter maximum and 
minimum, roundness, area, perimeter and circumfer-
ence for B16F10, vector clone PCD-1, cystatin clone 
CC12, clones 1-7 (N-terminal deletion) and 4-3 
(QLVA>GGGG) were analyzed using image J (NIH).  
Each of the clones was sparsely plated (5x104 
cells/35mm dish) onto 3 glass coverslips per dish per 
clone. After cells had flattened (6 hours), digital im-
ages were taken. Microscopy was performed with a 
Zeiss Axiovert 200M microscope using the 20x objec-
tive. Digital images of cells on the glass coverslips 
were captured with a Scion CFW-1310C digital cam-
era and Scion VisiCapture application software 
(version 4.7). When using the 20x objective, the field-
of-view was 145 x 130 µm at the detection surface of 
the camera. Images included 5 random fields for each 
coverslip and at least 100 cells were measured for each 
clone. Each assay was performed in triplicate, and data 
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Figure 1. Western blot analysis for cystatin C overexpres-
sion clones. Two independent B16F10 melanoma cell clones 
were analyzed for cystatin C production from serum free 
media by western blot as described in Materials and Meth-
ods section. PCD1 is the pcDNA3 plasmid clone 1;  CC9 
and CC12 are the cystatin C overexpression clones. 
Figure 2. Western blot analysis of cystatin C variant clones. 
N-terminal deletion (1-1 & 1-7) and QLVA > GGGG (4-3 & 
4-6) clones were analyzed for HA-antigen expression from 
serum free media by western blot as described in Materials 




is presented as mean ± standard error. 
 
Data Analysis 
Data were analyzed for statistical significance using an 
Analysis of Variance and a Tukey post-hoc multiple 
comparisons test. A general linear regression model 
was used to test for differences in cell morphology due 
to experimental design. Differences corresponding to p 




Cystatin C overexpression in B16F10 melanoma 
Murine cystatin C was overexpressed in B16F10 mela-
noma cells to serve as a control for cystatin variant 
clones. An increased level of secreted, 14kD cystatin C 
was detected for two overexpression clones (CC9 and 
CC12) by western blot analysis after a 48-hour culture 
in serum-free media (Figure 1). 
 
Western blot of cystatin C variant clones 
We aimed to establish what effects overexpression of 
cystatin C variants might have on the B16F10 in vitro 
behavior. To distinguish cystatin variant clone expres-
sion from endogenous cystatin C expression, we fused 
the variant cystatin constructs to HA tags. Western blot 
analysis after 48 hour, serum free culture of clones set 
1 (N-terminal deletion) and 4 (QLVA to GGGG) al-
lowed for detection of expression clones based on HA 
tag expression (Figure 2). The size of the expressed 
cystatin variants corresponded to the size of cystatin C 
(14kD). 
 
Cell proliferation assay 
To determine if cell proliferation rates were being al-
tered by overexpression of cystatin C constructs, we 
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Figure 3. Net cell proliferation for B16F10 and variant 
clones as determined by MTT assay.   
Figure 4.  (A) Melanoma cell migration determined by scratch assay. Scratches which denuded cells were made in cell plate 
wells. Cells were allowed to migrate for 24 hours before images were taken under bright field microscopy. Vector control = 
PCD1, WT cystatin = CC12 cystatin overexpressor. (B) Microscopy of scratch assays for cell migration for all clones tested at 
zero and twenty four hours. 
(a) (b) 
 
measured net proliferation of all clones using an MTT 
assay. There were no differences over time between 
each of the clones when measuring net proliferation 
rates (Figure 3). Therefore, clones of cystatin C ex-
pression constructs are not altered in net cell prolifera-
tion rates which could otherwise interfere with other 
results determined in this study. 
 
N-truncated cystatin C clone mimics CC12 in cell 
migration rates 
To evaluate if cysteine protease inhibition is crucial for 
decreased migration in vitro of B16F10 cells, scratch 
assays were performed with each clone. Figure 4 
shows the results of scratch migration assay for each 
clone. Mean migration rates in µm/hr were calculated 
for each clone. Migration rates were similar between 
the cystatin overexpression clone (CC12) and N-
terminal deletion clones 1-1 and 1-7. Migration rates 
were significantly different between the N-truncated 
clones 1-1 and 1-7 compared to the parental B16F10, 
vector control clone PD-1 and GGGG substitution 
clones  4-3 and 4-6. The QLVA to GGGG cystatin C 
construct clones mimicked B16F10 cell migration 
rates for 24 hours. 
 
N-truncated cystatin clones have equivalent anti-
invasion effects as CC12 
In order to evaluate changes in invasion for the differ-
ent cystatin clones, a modified Boyden chamber assay 
was implemented. There was a significant difference 
between CC12, 1-1 and 1-7 invasions when compared 
to the other clones. Clones 1-1 (99 cells), 1-7 (100 
cells) and CC12 (62 cells) were significantly lower 
than B16F10 (374 cells), PD-1 (392 cells), 4-3 (411 
cells) and 4-6 (406 cells). There was approximately a 4
-fold difference in invasion between clones 1 set and 
clones 4 set (Figure 5). The reduction in cell invasion 
through the membrane filter for N-truncated cystatin 
clones demonstrates how, even with cysteine protease 
inhibition activity missing for cystatin, there is still 
inhibition of invasion relative to control clones. 
   
Cellular morphology of N-truncated cystatin and 
GGGG substitution clones 
To determine cellular morphological changes between 
the different clones, cells of each clone were imaged 
with light microscopy with a 20x objective and ana-
lyzed with Image J. Feret diameter size, area, perime-
ter and circumference were not different between the 
clones (p > 0.05). Aspect ratio and roundness were, 
however, significantly different between the clones 
(Figure 6a and b). B16F10 cells were less elongated 
and more round than the cystatin overexpression clone 
(CC12). The mean aspect ratio and mean roundness for 
B16F10 compared to CC12 was 2.82 vs. 4.86 and 0.43 
vs. 0.28, respectively. A larger aspect ratio translates 
to a more elongated cell. With a roundness of 0.43, 
B16F10 is much more round compared to CC12 based 
on a scale of 0 to 1, with 1 being completely round. N-
terminal deletion (clone 1-7) and GGGG clone (clone 
4-6) were also analyzed for cell morphology. Clone 1-
7 had comparable aspect ratio and roundness as CC12, 
and both were statistically different from clone 4-6 and 
B16F10 values. Clone 4-6 showed aspect ratio and 
roundness values similar to B16F10. Mean aspect ratio 
and mean roundness for clones 1-7 and 4-6 were 4.57, 




The goal of this study was to study the effects of two 
different cystatin C construct clones on B16F10 in vi-
tro cell behavior by evaluating cell proliferation, mi-
gration, invasion and cell morphology. Previous work 
has shown cystatin C overexpression inhibits the me-
tastasis of B16 melanoma (Cox et al. 1999). Key 
changes induced by cystatin overexpression in the me-
tastasis of melanoma cells are both inhibition of cell 
migration/invasion and higher apoptosis induction in 
vivo (Ervin & Cox 2005). We initiated this study with 
a question as to whether melanoma cell migration/
invasion was inhibited by the cysteine protease inhibi-
tor action of cystatin. Two key different cystatin con-
struct clones were compared in their in vitro behavior 
to parental clones and cystatin overexpression clone – 
N-terminal cystatin deletion (not cathepsin inhibitory) 
and QLVA to GGGG construct. Net cell proliferation 
was not significantly different between control clones 
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Figure 5.  Melanoma cell invasion determined by Boyden-
type filter assay. Filters with 8μm pores were used in the 
assay.  Stained cells were counted under bright field micros-
copy. Vector control = PCD1, WT cystatin = CC12 cystatin 
overexpressor. 
and the cystatin overexpression or cystatin C variant 
clones in vitro. This result differs from the in vivo re-
sults of increased apoptosis with cystatin C overex-
pression and might be due to the growth factor-rich 
environment which exists in vitro. Alternatively, the 
concentration of secreted cystatin in cell culture may 
be insufficient to increase cell apoptosis as seen in 
vivo. We found that the evolutionarily conserved cys-
tatin QLVA sequence is necessary for obtaining cys-
tatin anti-migratory behavior when over-expressed in 
B16F10 cell line in vitro based on loss of function for 
QLVA variant clones. 
Since the N-truncated cystatin clones had mi-
gration and invasion rates comparable to wild type 
cystatin clone, the mechanism of inhibition should be 
similar. Previous studies in our laboratory have shown 
that overexpressed cystatin C decreases B16F10 mela-
noma cell migration and invasion both in vivo and in 
vitro by around 80% (Cox et al. 1999). Work by other 
laboratories have demonstrated the involvement of 
cysteine proteases in different aspects of cancer cell 
invasion, including human melanoma cells (Dennhofer 
et al. 2003, Fan et al. 2012, Levicar et al. 2003, Premzl 
et al. 2003, Quintanilla-Dieck et al. 2008). Although 
cathepsins undoubtedly play a role in cancer cell inva-
sion by degrading extracellular matrix proteins, their 
role in cancer cell migration is less clear. Two ways 
cathepsins may play a role in cell migration is by acti-
vating (proteolytic) migration factors and activation of 
migration related genes (non-proteolytic). Due to the 
first 10 amino acids of cystatin C being necessary for 
cysteine protease inhibition and binding, our findings 
suggest cysteine protease inhibition is not the main 
mechanism by which cystatin C is inhibiting mela-
noma migration, invasion and metastasis. 
Migration of melanoma cells resembles a snail
-like crawling involving focal adhesions in the case of 
epithelial to mesenchymal transition (EMT) or a 
weakly attached and gliding movement seen in amoe-
boid-style mode (Wolf et al. 2003). In EMT migration, 
cells exhibit an elongated morphology versus a 
rounder shape in the amoeboid-type.  B16F10 cells 
were morphologically very different compared to the 
cystatin C overexpression and N-terminal deleted 
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Figure 6. Morphology of melanoma cell clones. (A) Aspect 
ratio for several different melanoma clones. (B) Roundness 
determined for same set of clones as in A.  (C) Representa-
tive microscopy data illustrating cellular morphology of 
melanoma cell clones.  
  
clones. B16F10 cells had more filopodia-like struc-
tures and were less elongated. Filopodia have been 
shown to play a role in cell migration as protrusions 
containing actin cytoskeletal elements (Lidke et al. 
2005). The cystatin overexpression and N-truncated 
cystatin clones appeared to be very elongated, suggest-
ing reduced cell ability to undergo rear detachment 
from the surface and allow migration.  Calpains are 
cysteine proteases involved in cellular migration 
through mediating rear-end cellular detachment 
(Glading et al. 2002). Cystatins are not known to in-
hibit calpains, but the effect of cystatin inhibition of 
cell migration mimics the cell elongation effect that 
might be seen, for example, with calpain inhibition. 
More work will be required to determine why cystatin 
over-expression results in cancer cell elongation as it 
relates to decreased cell migration.  
Progression of melanoma from the primary 
tumor to a secondary site involves degradation and 
invasion through the basement membrane and angio-
genesis. Our results from the cell invasion assay dem-
onstrate that without the QLVA region, cystatin C can-
not inhibit B16F10 invasion, whereas deletion of the 
first 10 amino acids has little impact on decreasing 
cystatin C inhibition of B16F10 invasion. We propose 
that the QLVA region is interfering with some cell sig-
naling pathway required for melanoma cell migration/
invasion. In a prostate cancer cell line (PC3), cystatin 
C was shown to act as a factor that inhibited MAPK/
Erk2 pathway (Wegiel et al. 2009). MAPK signaling 
plays an important role in degrading the basement 
membrane, enhancing migration and maintaining tu-
mor cell growth (Sumimoto et al. 2004). We have not 
yet determined whether MAPK signaling may be 
linked to cystatin inhibition of invasion in B16 mela-
noma cells. 
The major conclusion of our study is that 
QLVA is the sequence of cystatin C necessary for its 
inhibition of migration and invasion for B16F10 cells.  
The cysteine proteinase inhibitor activity of cystatin C 
is not involved in inhibition of B16F10 invasion, but 
some other signaling pathway is probably being regu-
lated which contributes to the majority of the inhibi-
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